Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age

Salvatore Novo, Giuseppe Barbaro

    Risultato della ricerca: Article

    1 Citazione (Scopus)

    Abstract

    In pediatric age supraventricular tachiarrhythmias represent one of the most common cause of admission in cardiology units. Supraventricular arrhythmias may significantly influence the normal growth of a child with significant psycho-social implications. Pediatric cardiologists should be aware about the arrhythmias they face in their clinical practice. Moreover, they should know the possible risks related to specific arrhythmias and use the most efficacious therapeutic strategy with a correct knowledge of antiarrhythmic drugs. In this issue of Current Pharmacological Design the most recent knowledges on pathophysiology, diagnosis and treatment of supraventricular tachyarrhythmias in pediatric age are reviewed and discussed by recognized opinion leaders in the field
    Lingua originaleEnglish
    pagine (da-a)722-722
    Numero di pagine1
    RivistaCurrent Pharmaceutical Design
    Volume14
    Stato di pubblicazionePublished - 2008

    Fingerprint

    Supraventricular Tachycardia
    Pediatrics
    Anti-Arrhythmia Agents
    Cardiology
    Cardiac Arrhythmias
    Therapeutics
    Pharmacology
    Growth

    All Science Journal Classification (ASJC) codes

    • Molecular Medicine
    • Pharmacology, Toxicology and Pharmaceutics(all)

    Cita questo

    Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age. / Novo, Salvatore; Barbaro, Giuseppe.

    In: Current Pharmaceutical Design, Vol. 14, 2008, pag. 722-722.

    Risultato della ricerca: Article

    Novo, S & Barbaro, G 2008, 'Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age', Current Pharmaceutical Design, vol. 14, pagg. 722-722.
    Novo S, Barbaro G. Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age. Current Pharmaceutical Design. 2008;14:722-722.
    Novo, Salvatore ; Barbaro, Giuseppe. / Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age. In: Current Pharmaceutical Design. 2008 ; Vol. 14. pagg. 722-722.
    @article{a0710b06647647e49c25eed53d8d6d4c,
    title = "Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age",
    abstract = "In pediatric age supraventricular tachiarrhythmias represent one of the most common cause of admission in cardiology units. Supraventricular arrhythmias may significantly influence the normal growth of a child with significant psycho-social implications. Pediatric cardiologists should be aware about the arrhythmias they face in their clinical practice. Moreover, they should know the possible risks related to specific arrhythmias and use the most efficacious therapeutic strategy with a correct knowledge of antiarrhythmic drugs. In this issue of Current Pharmacological Design the most recent knowledges on pathophysiology, diagnosis and treatment of supraventricular tachyarrhythmias in pediatric age are reviewed and discussed by recognized opinion leaders in the field",
    author = "Salvatore Novo and Giuseppe Barbaro",
    year = "2008",
    language = "English",
    volume = "14",
    pages = "722--722",
    journal = "Current Pharmaceutical Design",
    issn = "1381-6128",
    publisher = "Bentham Science Publishers B.V.",

    }

    TY - JOUR

    T1 - Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age

    AU - Novo, Salvatore

    AU - Barbaro, Giuseppe

    PY - 2008

    Y1 - 2008

    N2 - In pediatric age supraventricular tachiarrhythmias represent one of the most common cause of admission in cardiology units. Supraventricular arrhythmias may significantly influence the normal growth of a child with significant psycho-social implications. Pediatric cardiologists should be aware about the arrhythmias they face in their clinical practice. Moreover, they should know the possible risks related to specific arrhythmias and use the most efficacious therapeutic strategy with a correct knowledge of antiarrhythmic drugs. In this issue of Current Pharmacological Design the most recent knowledges on pathophysiology, diagnosis and treatment of supraventricular tachyarrhythmias in pediatric age are reviewed and discussed by recognized opinion leaders in the field

    AB - In pediatric age supraventricular tachiarrhythmias represent one of the most common cause of admission in cardiology units. Supraventricular arrhythmias may significantly influence the normal growth of a child with significant psycho-social implications. Pediatric cardiologists should be aware about the arrhythmias they face in their clinical practice. Moreover, they should know the possible risks related to specific arrhythmias and use the most efficacious therapeutic strategy with a correct knowledge of antiarrhythmic drugs. In this issue of Current Pharmacological Design the most recent knowledges on pathophysiology, diagnosis and treatment of supraventricular tachyarrhythmias in pediatric age are reviewed and discussed by recognized opinion leaders in the field

    UR - http://hdl.handle.net/10447/277262

    M3 - Article

    VL - 14

    SP - 722

    EP - 722

    JO - Current Pharmaceutical Design

    JF - Current Pharmaceutical Design

    SN - 1381-6128

    ER -

    Accesso al documento